Methods for in vivo identification of cancer initiating cells by multimodality reporter gene imaging
US-9220793-B2 · Dec 29, 2015 · US
US10000518B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10000518-B2 |
| Application number | US-72156305-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 18, 2005 |
| Priority date | Dec 22, 2004 |
| Publication date | Jun 19, 2018 |
| Grant date | Jun 19, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-ß-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
Opening claim text (preview).
What is claimed is: 1. A method of storing 1,3,4,6-tetra-O-acetyl-2O-trifluoromethanesulfonyl-β-D-mannopyranose (mannose triflate), the method comprising dissolving mannose triflate in acetonitrile to form a solution and storing the solution in a sealed container for subsequent storage, wherein the solution consists of mannose triflate and acetonitrile, wherein the stability of the mannose triflate stored in the acetonitrile is better than the stability of mannose triflate stored without the acetonitrile, and wherein the acetonitrile has a water content between 100 ppm and 50000 ppm. 2. The method of claim 1 , wherein the concentration of the mannose triflate in the solution is between 10 mg/mL to 18 mg/mL. 3. The method of claim 1 , wherein the sealed container is a septum-sealed vial. 4. The method of claim 1 , wherein the acetonitrile has a water content of approximately 600 ppm. 5. The method of claim 1 , wherein the acetonitrile has a water content between 100 ppm and 600 ppm.
to halogen · CPC title
Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers · CPC title
Processes for the preparation of sugar derivatives · CPC title
Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium · CPC title
having the esterifying carboxyl radicals attached to acyclic carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.